D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$315M |
| 2 |
Exxon Mobil
XOM
|
+$312M |
| 3 |
Verizon
VZ
|
+$289M |
| 4 |
Procter & Gamble
PG
|
+$288M |
| 5 |
Pfizer
PFE
|
+$272M |
Top Sells
| 1 |
Tesla
TSLA
|
+$619M |
| 2 |
Biogen
BIIB
|
+$369M |
| 3 |
Amazon
AMZN
|
+$341M |
| 4 |
Netflix
NFLX
|
+$309M |
| 5 |
Emerson Electric
EMR
|
+$306M |
Sector Composition
| 1 | Technology | 23.54% |
| 2 | Healthcare | 14.5% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 9.56% |
| 5 | Communication Services | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Gentex
GNTX
$6.15B
| $10.3M | 0.02% |
465,948
-334,044
| -42% | -$7.4M |
|
|
PXD
702
DELISTED
Pioneer Natural Resource Co.
PXD
| $10.3M | 0.02% |
146,428
-23,134
| -14% | -$1.62M |
|
703
Extreme Networks
EXTR
$2.96B
| $10.3M | 0.02% |
3,324,037
+583,263
| +21% | +$1.8M |
|
704
Equifax
EFX
$30.3B
| $10.3M | 0.02% |
85,890
+69,090
| +411% | +$8.25M |
|
705
Healthcare Services Group
HCSG
$1.15B
| $10.2M | 0.02% |
428,535
+126,373
| +42% | +$3.02M |
|
706
Upbound Group
UPBD
$1.47B
| $10.2M | 0.02% |
722,087
+140,483
| +24% | +$1.99M |
|
707
Omnicom Group
OMC
$14.7B
| $10.2M | 0.02% |
+185,663
| New | +$10.2M |
|
708
LPL Financial
LPLA
$27.4B
| $10.1M | 0.02% |
185,383
+24,949
| +16% | +$1.36M |
|
709
Veeco
VECO
$1.52B
| $10.1M | 0.02% |
1,051,028
-144,678
| -12% | -$1.38M |
|
710
Sensata Technologies
ST
$4.59B
| $9.97M | 0.02% |
344,625
+180,094
| +109% | +$5.21M |
|
711
Akebia Therapeutics
AKBA
$777M
| $9.95M | 0.02% |
1,311,965
+524,334
| +67% | +$3.97M |
|
|
LGF.B
712
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $9.91M | 0.02% |
1,776,252
-350,531
| -16% | -$1.96M |
|
713
Apellis Pharmaceuticals
APLS
$3.29B
| $9.91M | 0.02% |
369,733
+221,326
| +149% | +$5.93M |
|
714
Haemonetics
HAE
$2.59B
| $9.9M | 0.02% |
99,285
-3,089
| -3% | -$308K |
|
|
VAR
715
DELISTED
Varian Medical Systems, Inc.
VAR
| $9.87M | 0.02% |
96,160
-161,598
| -63% | -$16.6M |
|
716
Littelfuse
LFUS
$6.54B
| $9.82M | 0.02% |
73,621
+27,136
| +58% | +$3.62M |
|
|
NBIS
717
Nebius Group N.V. Class A Ordinary Shares
NBIS
$22.3B
| $9.74M | 0.02% |
286,078
+84,544
| +42% | +$2.88M |
|
|
TWNK
718
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $9.69M | 0.02% |
909,062
-909,264
| -50% | -$9.69M |
|
|
KSU
719
DELISTED
Kansas City Southern
KSU
| $9.68M | 0.02% |
76,125
+7,261
| +11% | +$923K |
|
720
Selective Insurance
SIGI
$4.75B
| $9.68M | 0.02% |
194,707
+19,197
| +11% | +$954K |
|
721
A.O. Smith
AOS
$10.2B
| $9.65M | 0.02% |
255,175
-51,006
| -17% | -$1.93M |
|
722
Insulet
PODD
$23.8B
| $9.64M | 0.02% |
58,161
-89,452
| -61% | -$14.8M |
|
|
BMY.RT
723
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $9.59M | 0.02% |
2,524,432
-50,356
| -2% | -$191K |
|
724
ScottsMiracle-Gro
SMG
$3.5B
| $9.56M | 0.01% |
93,353
+82,812
| +786% | +$8.48M |
|
725
Central Garden & Pet Class A
CENTA
$2.07B
| $9.55M | 0.01% |
466,821
-147,155
| -24% | -$3.01M |
|